Endothelial dysfunction, inflammation and diabetes

Rev Endocr Metab Disord. 2004 Aug;5(3):189-97. doi: 10.1023/B:REMD.0000032407.88070.0a.
No abstract available

Publication types

  • Review

MeSH terms

  • Acarbose / immunology
  • Acarbose / therapeutic use
  • Animals
  • Cardiovascular Agents / immunology*
  • Cardiovascular Agents / therapeutic use
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / immunology*
  • Diabetic Angiopathies / drug therapy
  • Diabetic Angiopathies / immunology*
  • Endothelium, Vascular / immunology*
  • Humans
  • Hypoglycemic Agents / immunology*
  • Hypoglycemic Agents / therapeutic use
  • Inflammation / immunology*
  • Insulin Resistance / immunology
  • Metformin / immunology
  • Metformin / therapeutic use
  • Obesity / immunology
  • Oxidative Stress / immunology
  • Sulfonylurea Compounds / immunology
  • Sulfonylurea Compounds / therapeutic use
  • Thiazolidinediones / immunology
  • Thiazolidinediones / therapeutic use

Substances

  • Cardiovascular Agents
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Thiazolidinediones
  • Metformin
  • Acarbose